PharmaResources (Shanghai) Co. Ltd. A (301230) — Capital Reinvestment Ratio
PharmaResources (Shanghai) Co. Ltd. A (301230) has a Capital Reinvestment Ratio of 0.32x as of December 2025, meaning it reinvests 0% of its operating cash flow (CN¥135.51 Million) in capital expenditures (CN¥43.32 Million). See PharmaResources (Shanghai) Co. Ltd. A free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
PharmaResources (Shanghai) Co. Ltd. A Capital Reinvestment Ratio (2020–2025)
This chart tracks PharmaResources (Shanghai) Co. Ltd. A's Capital Reinvestment Ratio across 6 annual periods.
Annual Capital Reinvestment Ratio for PharmaResources (Shanghai) Co. Ltd. A (2020–2025)
Year-by-year Capital Reinvestment Ratio for PharmaResources (Shanghai) Co. Ltd. A from 2020 to 2025. For live market cap and broader valuation context, see 301230 stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.32x | CN¥135.51 Million | CN¥43.32 Million | ▼ -76.4% |
| 2024 | 1.35x | CN¥80.86 Million | CN¥109.40 Million | ▼ -88.6% |
| 2023 | 11.90x | CN¥20.86 Million | CN¥248.27 Million | ▲ +853.4% |
| 2022 | 1.25x | CN¥99.29 Million | CN¥123.97 Million | ▲ +42.5% |
| 2021 | 0.88x | CN¥105.12 Million | CN¥92.12 Million | ▲ +42.4% |
| 2020 | 0.62x | CN¥54.45 Million | CN¥33.51 Million | — |